These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 18987608)

  • 41. Physical training increases renal injury in rats with chronic NOS inhibition.
    Kuru O; Sentürk UK; Gülkesen H; Demir N; Gündüz F
    Ren Fail; 2005; 27(4):459-63. PubMed ID: 16060136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of antihypertensive drugs on nitric oxide synthase activity in rat kidney.
    Tojo A; Kobayashi N; Kimura K; Hirata Y; Matsuoka H; Yagi S; Omata M
    Kidney Int Suppl; 1996 Jun; 55():S138-40. PubMed ID: 8743536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolonged inhibition of nitric oxide synthesis in pregnant rats: effects on blood pressure, fetal growth and litter size.
    Fernández Celadilla L; Carbajo Rueda M; Muñoz Rodríguez M
    Arch Gynecol Obstet; 2005 Mar; 271(3):243-8. PubMed ID: 15791477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of propolis on tyrosine hydroxylase activity and blood pressure in nitric oxide synthase-inhibited hypertensive rats.
    Gogebakan A; Talas ZS; Ozdemir I; Sahna E
    Clin Exp Hypertens; 2012; 34(6):424-8. PubMed ID: 22471835
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of exercise training on resistance arteries in rats with chronic NOS inhibition.
    Kuru O; Sentürk UK; Koçer G; Ozdem S; Başkurt OK; Cetin A; Yeşilkaya A; Gündüz F
    J Appl Physiol (1985); 2009 Sep; 107(3):896-902. PubMed ID: 19498093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Opening of ATP-sensitive potassium channel attenuates cardiac remodeling induced by chronic inhibition of nitric oxide synthesis].
    Sanada S; Node K; Asanuma H; Ogita H; Takashima S; Minamino T; Asakura M; Hori M; Kitakaze M
    J Cardiol; 2003 Jan; 41(1):43-4. PubMed ID: 12564115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is there a link between salt-intake and atrial natriuretic peptide system during hypertension induced by nitric oxide blockade?
    Marchi Alves LM; Tosi LR; Antunes-Rodrigues J; Cárnio EC
    Regul Pept; 2004 Aug; 120(1-3):127-32. PubMed ID: 15177930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition.
    Kaikita K; Schoenhard JA; Painter CA; Ripley RT; Brown NJ; Fogo AB; Vaughan DE
    J Mol Cell Cardiol; 2002 Jun; 34(6):617-27. PubMed ID: 12054849
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low doses of ethanol decrease the activity of the angiotensin-converting enzyme in the aorta of aging rats and rats treated with a nitric oxide synthase inhibitor and dexamethasone.
    Emel'yanov MO; Korystova AF; Kublik LN; Levitman MKh; Shaposhnikova VV; Korystov YN
    Clin Sci (Lond); 2012 Jan; 122(2):75-81. PubMed ID: 21767262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Local nitric oxide synthase inhibition reduces skeletal muscle glucose uptake but not capillary blood flow during in situ muscle contraction in rats.
    Ross RM; Wadley GD; Clark MG; Rattigan S; McConell GK
    Diabetes; 2007 Dec; 56(12):2885-92. PubMed ID: 17881613
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nitric oxide synthases are involved in the modulation of cardiovascular adaptation in hemorrhaged rats.
    Balaszczuk AM; Arreche ND; Mc Laughlin M; Arranz C; Fellet AL
    Vascul Pharmacol; 2006 Jun; 44(6):417-26. PubMed ID: 16697268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular effects of chronic nitric oxide synthase inhibition in genetically hypertensive rats.
    Orange SJ; Ledingham JM; Laverty R
    Clin Exp Pharmacol Physiol; 2000 Jul; 27(7):488-93. PubMed ID: 10874504
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats.
    Paulis L; Pechanova O; Zicha J; Krajcirovicova K; Barta A; Pelouch V; Adamcova M; Simko F
    J Hypertens Suppl; 2009 Aug; 27(6):S11-6. PubMed ID: 19633445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microinjection of the nitric oxide synthase inhibitor L-NAME into the lateral basal forebrain alters the sleep/wake cycle of the rat.
    Monti JM; Jantos H
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):239-47. PubMed ID: 14751418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nitric oxide pathway is an important modulator of heat loss in rats during exercise.
    Lacerda AC; Marubayashi U; Coimbra CC
    Brain Res Bull; 2005 Sep; 67(1-2):110-6. PubMed ID: 16140169
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ferulic acid restores endothelium-dependent vasodilation in aortas of spontaneously hypertensive rats.
    Suzuki A; Yamamoto M; Jokura H; Fujii A; Tokimitsu I; Hase T; Saito I
    Am J Hypertens; 2007 May; 20(5):508-13. PubMed ID: 17485012
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural alterations in the heart after long-term L-NAME and D-NAME treatment.
    Pechánová O; Bernátová I; Babál P
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():6-9. PubMed ID: 10707823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
    Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-lipid deposition effect of HMG-CoA reductase inhibitor, pitavastatin, in a rat model of hypertension and hypercholesterolemia.
    Kumai T; Oonuma S; Matsumoto N; Takeba Y; Taniguchi R; Kamio K; Miyazu O; Koitabashi Y; Sekine S; Tadokoro M; Kobayashi S
    Life Sci; 2004 Mar; 74(17):2129-42. PubMed ID: 14969717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.